Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07016620

Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia

Sponsor: The Cleveland Clinic

View on ClinicalTrials.gov

Summary

Benign prostatic hyperplasia (BPH) is a common condition affecting aging men, often leading to lower urinary tract symptoms (LUTS). While Minimally Invasive Surgical Therapies (MIST) procedures offer less invasive alternatives to traditional surgery, some patients experience symptom recurrence or require further intervention due to lack of adequate relief of obstruction. Treatment of persistent obstruction after MIST therapy (BPH salvage therapy) typically requires surgical intervention like transurethral resection of prostate (TURP). This study proposes to evaluate the effectiveness of in-office transperineal laser ablation (TPLA) using the Echolaser system as a minimally invasive treatment option for these patients, potentially avoiding more invasive surgical procedures. The Cleveland Clinic sees a high volume of BPH salvage patients, making this an ideal setting for this research.

Official title: In-Office Transperineal Laser Ablation (TPLA) as a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia (BPH) After Minimally Invasive Surgical Therapies (MIST)

Key Details

Gender

MALE

Age Range

40 Years - Any

Study Type

OBSERVATIONAL

Enrollment

20

Start Date

2026-01-12

Completion Date

2027-09-01

Last Updated

2026-02-05

Healthy Volunteers

Not specified

Interventions

PROCEDURE

Transperineal Laser Ablation (TPLA)

Outpatient treatment with Transperineal Laser Ablation (TPLA) as a salvage therapy after previous Minimally Invasive Surgical Therapies (MIST)

Locations (1)

Cleveland Clinic

Cleveland, Ohio, United States